Tyler Zeronda
Director of Finance/CFO chez VYNE THERAPEUTICS INC.
Fortune : 404 451 $ au 31/03/2024
Profil
Tyler Zeronda is currently the Chief Financial Officer & Treasurer at VYNE Therapeutics, Inc. He previously worked as the Director-Finance at Aerie Pharmaceuticals, Inc. Mr. Zeronda holds a graduate degree from the University of Virginia and an undergraduate degree from Lafayette College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VYNE THERAPEUTICS INC
0,93% | 01/04/2024 | 131 743 ( 0,93% ) | 404 451 $ | 31/03/2024 |
Postes actifs de Tyler Zeronda
| Sociétés | Poste | Début |
|---|---|---|
| VYNE THERAPEUTICS INC. | Director of Finance/CFO | 18/06/2021 |
Anciens postes connus de Tyler Zeronda
| Sociétés | Poste | Fin |
|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Director of Finance/CFO | - |
Formation de Tyler Zeronda
| University of Virginia | Graduate Degree |
| Lafayette College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
| VYNE Therapeutics, Inc. |
